ExodusPoint Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-314,407
| Closed | -$3.86M | – | 1853 |
|
|
2025
Q1 | $3.86M | Buy |
314,407
+165,839
| +112% | +$2.04M | 0.04% | 462 |
|
|
2024
Q4 | $1.96M | Sell |
148,568
-169,826
| -53% | -$2.25M | 0.01% | 653 |
|
|
2024
Q3 | $6.13M | Sell |
318,394
-307,329
| -49% | -$5.92M | 0.04% | 316 |
|
|
2024
Q2 | $12.8M | Buy |
625,723
+339,393
| +119% | +$6.97M | 0.09% | 178 |
|
|
2024
Q1 | $6.82M | Sell |
286,330
-66,922
| -19% | -$1.59M | 0.05% | 246 |
|
|
2023
Q4 | $7.63M | Buy |
353,252
+197,538
| +127% | +$4.27M | 0.05% | 219 |
|
|
2023
Q3 | $2.26M | Sell |
155,714
-50,004
| -24% | -$726K | 0.02% | 601 |
|
|
2023
Q2 | $4.31M | Buy |
205,718
+143,845
| +232% | +$3.01M | 0.04% | 438 |
|
|
2023
Q1 | $1.31M | Buy |
+61,873
| New | +$1.31M | 0.01% | 951 |
|
|
2022
Q4 | – | Sell |
-58,466
| Closed | -$1.41M | – | 2033 |
|
|
2022
Q3 | $1.41M | Sell |
58,466
-1,891
| -3% | -$45.4K | 0.02% | 928 |
|
|
2022
Q2 | $1.16M | Buy |
60,357
+40,684
| +207% | +$783K | 0.01% | 964 |
|
|
2022
Q1 | $342K | Buy |
+19,673
| New | +$342K | ﹤0.01% | 1655 |
|
|
2021
Q2 | – | Sell |
-10,359
| Closed | -$232K | – | 2686 |
|
|
2021
Q1 | $232K | Buy |
+10,359
| New | +$232K | ﹤0.01% | 1767 |
|